Brief: Cipher pharmaceuticals sees Q2 total revenue of about $11.7 mln

Cipher Pharmaceuticals

03/08/2016 13:51

Aug 3 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO  
    * Cipher pharmaceuticals announces preliminary q2 2016 
results highlighted by 30+% revenue growth and $3.0+million cash 
from operations 
    * Sees net loss of about $3.4 million, or $0.13 per basic 
share for q2 
    * Q2 revenue view $11.1 million -- Thomson Reuters I/B/E/S 
    * Sees q2 total revenue of approximately $11.7 million, an 
increase of more than 30% from $8.8 million in q2 2015 
 
Source text for Eikon:  ID:nCNWy74CLa  
Further company coverage:  CPH.TO  
 
 (Bengaluru Newsroom: +1-646-223-8780)